Skip to content

ARROWHEAD PHARMACEUTICALS, INC.: 10-Q filed 2011-08-08

What ARROWHEAD PHARMACEUTICALS, INC. reported in its quarterly report filed 2011-08-08 (fiscal Q3 2011): 35 published measures, 124 facts as tagged in accession 0001193125-11-214223.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-08
Fiscal period
fiscal Q3 2011
Accession
0001193125-11-214223 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARROWHEAD PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-3013,289,834USD
At 2010-09-3012,354,542USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-3010,625,775USD
At 2010-09-309,045,702USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-304,316,308USD
At 2010-09-306,847,162USD
At 2010-06-308,983,445USD
At 2009-09-302,020,224USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,819,917USD91
2010-10-01 to 2011-06-30-352,362USD273
2003-05-07 to 2011-06-30-110,931,269USD2977
2009-10-01 to 2010-09-30-6,957,038USD365
2010-04-01 to 2010-06-30-371,055USD91
2009-10-01 to 2010-06-30-3,769,942USD273
2008-10-01 to 2009-09-30-19,308,392USD365
2007-10-01 to 2008-09-30-27,241,639USD366
2006-10-01 to 2007-09-30-30,712,947USD365
2005-10-01 to 2006-09-30-19,961,961USD365
2004-10-01 to 2005-09-30-6,733,427USD365
2003-10-01 to 2004-09-30-751,255USD366
2002-10-01 to 2003-09-30-95,238USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2010-10-01 to 2011-06-309,674USD273
2003-05-07 to 2011-06-303,565,599USD2977

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2010-10-01 to 2011-06-30296,139USD273
2003-05-07 to 2011-06-303,991,959USD2977

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-30-111,095,229USD
At 2010-09-30-110,742,867USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-04-01 to 2011-06-3071,826,276shares91
2010-10-01 to 2011-06-3071,804,027shares273
2010-04-01 to 2010-06-3064,579,403shares91
2009-10-01 to 2010-06-3062,056,412shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-04-01 to 2011-06-3071,826,276shares91
2010-10-01 to 2011-06-3078,567,954shares273
2010-04-01 to 2010-06-3064,579,403shares91
2009-10-01 to 2010-06-3062,056,412shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-0.03USD/shares91
2010-04-01 to 2010-06-30-0.01USD/shares91
2009-10-01 to 2010-06-30-0.06USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-0.03USD/shares91
2010-04-01 to 2010-06-30-0.01USD/shares91
2009-10-01 to 2010-06-30-0.06USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-3029,921USD
At 2010-09-30141,269USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-04-01 to 2011-06-30346,707USD91
2010-10-01 to 2011-06-301,078,951USD273
2003-05-07 to 2011-06-3012,042,095USD2977
2010-04-01 to 2010-06-30390,227USD91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,770,165USD91
2010-10-01 to 2011-06-30-6,917,550USD273
2003-05-07 to 2011-06-30-93,214,087USD2977
2010-04-01 to 2010-06-30-1,391,561USD91
2009-10-01 to 2010-06-30-4,047,755USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-307,048,556USD
At 2010-09-308,131,775USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-302,159,704USD
At 2010-09-304,276,246USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-06-30501,278USD
At 2010-09-30681,563USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2010-09-3058,864USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,770,165USD91
2010-10-01 to 2011-06-307,213,689USD273
2003-05-07 to 2011-06-3097,206,046USD2977
2010-04-01 to 2010-06-301,391,561USD91
2009-10-01 to 2010-06-304,047,755USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-30365,618USD91
2010-10-01 to 2011-06-302,768,130USD273
2003-05-07 to 2011-06-3039,919,100USD2977
2010-04-01 to 2010-06-30123,343USD91
2009-10-01 to 2010-06-30372,554USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3071,833,693shares
At 2010-09-3071,720,137shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-06-3010,569,252USD
At 2010-09-308,078,296USD
At 2009-09-304,857,936USD
At 2008-09-3012,302,609USD
At 2007-09-3026,456,577USD
At 2006-09-3031,605,644USD
At 2005-09-3028,026,657USD
At 2004-09-3011,227,149USD
At 2003-09-301,419,762USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2011-06-30365,801USD
At 2010-09-301,317,673USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-06-30335,880USD
At 2010-09-301,176,404USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-06-306,211,357USD
At 2010-09-304,081,498USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-06-30472,279USD
At 2010-09-30494,736USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-06-30204,642USD
At 2010-09-30353,930USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,944,672USD91
2010-10-01 to 2011-06-30-5,838,432USD273
2003-05-07 to 2011-06-30-85,757,732USD2977
2010-04-01 to 2010-06-3084,364USD91
2009-10-01 to 2010-06-30-2,689,534USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-2,013,414USD91
2010-10-01 to 2011-06-30-545,461USD273
2003-05-07 to 2011-06-30-128,595,344USD2977
2010-04-01 to 2010-06-30-683,796USD91
2009-10-01 to 2010-06-30-4,642,822USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30643,165USD91
2010-10-01 to 2011-06-302,097,538USD273
2003-05-07 to 2011-06-3023,866,803USD2977
2010-04-01 to 2010-06-30736,443USD91
2009-10-01 to 2010-06-301,796,326USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2010-10-01 to 2011-06-30203,041USD273
2003-05-07 to 2011-06-305,595,375USD2977
2009-10-01 to 2010-06-30209,450USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-04-01 to 2011-06-3060,452USD91
2010-10-01 to 2011-06-30181,356USD273
2003-05-07 to 2011-06-301,721,492USD2977
2010-04-01 to 2010-06-3060,452USD91
2009-10-01 to 2010-06-30181,356USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-174,507USD91
2010-10-01 to 2011-06-301,079,118USD273
2003-05-07 to 2011-06-307,456,355USD2977
2010-04-01 to 2010-06-301,475,925USD91
2009-10-01 to 2010-06-301,358,221USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-10-01 to 2011-06-3057,163USD273
2003-05-07 to 2011-06-3090,844,554USD2977
2009-10-01 to 2010-06-3012,071,255USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2010-10-01 to 2011-06-3081,554USD273
2003-05-07 to 2011-06-30130,909USD2977
2009-10-01 to 2010-06-30303,854USD273

Inspect the source

Entity
ARROWHEAD PHARMACEUTICALS, INC. / CIK 0000879407
Captured
2026-09-20T05:01:27.924Z
SEC response SHA-256
df8855dae0055b71bd49c85d7ebc47f72ea6d71536d6bfd857bed2fe95364863

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000879407.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))